Highlights of Cardiovascular disease prevention studies presented at the 2024 European society of cardiology congress
Document Type
Article
Department
Medicine; Office of the Provost
Abstract
Purpose of review: To summarize selected late-breaking science on cardiovascular disease (CVD) prevention presented at the 2024 European Society of Cardiology (ESC) Congress.
Recent findings: Key studies from the 2024 ESC Congress highlight advances in (CVD) management. Apolipoprotein A-1 infusions reduced risk in acute myocardial infarction patients with high LDL cholesterol. Plozasiran cut triglycerides and apolipoprotein C-III levels, lowering pancreatitis risk. A 14-year study linked smoking among youth to cardiac abnormalities. Baseline hsCRP, LDL-C, and Lp(a) were strong predictors of 30-year outcomes in women. Alternative LDL-lowering strategies matched high-intensity statins in effectiveness of LDL-C lowering and reduced diabetes risk. Early combination lipid lowering therapy improved outcomes post-myocardial infarction. Nordic and Mediterranean diets were linked to lower atherosclerotic CVD risk. The findings from the 2024 ESC Congress highlight significant advancements in CVD prevention, including novel lipid-lowering therapies, biomarker-based risk prediction, and lifestyle interventions. These studies underscore the importance of early and personalized treatment strategies to mitigate long-term cardiovascular risk
Publication (Name of Journal)
Current Atherosclerosis Reports
DOI
10.1007/s11883-024-01253-z
Recommended Citation
Junaid, V.,
Minhas, A. K.,
Inam, M.,
Hinkamp, C.,
Talha, K. M.,
Meloche, C.,
Sheikh, S.,
Khoja, A.,
Virani, S. S.,
Vaughan, E. M.
(2024). Highlights of Cardiovascular disease prevention studies presented at the 2024 European society of cardiology congress. Current Atherosclerosis Reports, 27(1).
Available at:
https://ecommons.aku.edu/provost_office/819
Comments
Pagination is not provided by author/publisher